Patient Selection
The study population is patients older than 18 years old who visited Fatemeh Zahra Sari Heart Hospital, located in the north of Iran, between September 2017 and August 2018 and underwent PPCI with STEMI. The people in the study included patients who had chest pain suggestive of myocardial infarction from at least 30 minutes before admission to a maximum of 12 hours before going to the hospital with an ECG suggestive of STEMI.
Patients who presented with cardiogenic shock, patients who became candidates for PCI after receiving fibrinolytics, patients who became candidates for emergent CABGs after angiography, patients under 18 years old or over 80 years old, pregnant patients, patients with kidney or liver failure and Patients who had contraindications for eptifibatide use (active internal bleeding, brain neoplasm or aneurysm, stroke in the last two years, intracerebral trauma or surgery in the last two months, uncontrolled high blood pressure, and thrombocytopenia) were excluded from the study.